Skip to main content

Table 2 Descriptive statistics for clinical outcome measures

From: Comparative effects of EMG-driven robot-assisted therapy versus task-oriented training on motor and daily function in patients with stroke: a randomized cross-over trial

Outcome measure

Baseline

End of robot-assisted intervention

End of conventional intervention

Group A

Group B

Group A

Group B

Group A

Group B

FMA-UE

33 (8.53)

36.4 (10.1)

35.64 (9.3)

34.7 (11.02)

36.43 (9.53)

38.8 (10.32)

WMFT-Time

14.85 (6.19)

12.09 (6.5)

12.52 (5.92)

9.07 (4.51)

12.41 (6.21)

11.05 (6.03)

WMFT-FAS

2.51 (.44)

2.65 (.71)

2.63 (.58)

2.83 (.77)

2.75 (.7)

3.31 (.99)

MAL-AOU

1.15 (.82)

.97 (1.13)

1.33(.82)

1.09 (1.15)

1.58 (1.04)

1.25 (1.27)

MAL-QOM

.76 (.48)

.78 (.95)

.86(.56)

1.12 (1.07)

1.08 (.76)

.89 (.94)

ARAT

14.5 (9.24)

18.8 (12.13)

16(9.03)

22.4 (10.34)

20.07 (13.98)

21.9 (15.2)

  1. Data are presented as the mean (SD)
  2. FMA_UE upper limb subtest of the Fugl-Meyer assessment, WMFT-Time performance time of the Wolf Motor Function Test, WMFT-FAS functional ability scale of the Wolf Motor Function Test, MAL-AOU Motor Activity Log Amount of use score, MAL-QOM Motor Activity Log Quality of movement score, ARAT Action Research Arm Test